Contact X-ray brachytherapy boost bolsters 3-year organ preservation rate in rectal cancer

Chemoradiotherapy with a contact X-ray brachytherapy boost significantly increased clinical complete response and 3-year organ preservation rates in patients with early cT2-cT3 rectal adenocarcinoma, particularly tumors smaller than 3 cm.“The standard of care for rectal cT2 to cT3 adenocarcinoma is radical proctectomy by total mesorectal excision, sometimes preceded by neoadjuvant chemoradiotherapy, external beam radiotherapy or total neoadjuvant treatment,” Jean-Pierre Gerard, MD, of the Antoine Lacassagne Center at Côte d’Azur University in France, and colleagues wrote inRead More